During 4 years, 51 patients with retinoblastoma were studied (unilateral 32, and bilateral 19). Treatment consisted of enucleation of those eyes which showed massive involvement followed by radiotherapy when there was optic nerve and/or orbit involvement. Systemic chemotherapy was administered to al
A prospective study on the treatment of retinoblastoma in 72 patients
β Scribed by Marta Zelter; Angelica Damel; Guillermo Gonzalez; Laura Schwartz
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 597 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Seventy-two patients with retinoblastoma (RTB) (unilateral (47 patients] and bilateral [25 patients]) were studied for a period of 6 years. Treatment consisted of enucleation of those eyes that had severe involvement and was followed by radiation therapy and/or chemotherapy (systemic or intrathecal) according to clinical pathologic staging. All patients who underwent nonsurgical treatment received systemic chemotherapy. Intrathecal chemotherapy was administered when there was involvement of the central nervous system. Nonsurgical treatment consisted of radiation therapy and/or light coagulation, followed by enucleation if there was no response. The overall survival rates were 79% for unilateral disease (median follow-up time, 63 months) and 72% for bilateral disease (median followup time, 81 months). Vision was regained in 14 of 21 conserved eyes.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The objectives of this prospective study were to avoid adjuvant treatment for patients with intraocular disease and patients with postlaminar optic nerve invasion (PLβONI) without full choroidal or scleral invasion. Adjuvant chemotherapy (Regimen 1) was given to patients
## Abstract A prospective study was made of changes in the electroencephalogram after the use of metrizamide for myelography and posterior fossa cisternography in 61 patients (62 studies). The EEG changed in 21 patients (34%); 3 of these had had previously abnormal records, and the abnormalities we
## Abstract ## BACKGROUND. Because medulloblastoma (MB) is rare in adults, the few studies on this condition have been retrospective, and the followβup has tended to be short. Furthermore, the different therapeutic strategies used in these patients has made it difficult to assess survival rates an